Patients with moderate and severe infection experienced a 17.50% and 23.16% decrease in estimated glomerular filtration rate (eGFR), respectively, from baseline (before testing positive for SARS-CoV-2) to 90 days after the positive test.
HCV+ deceased donor kidney transplantations have increased in recent years in response to the availability of highly effective direct-acting antiviral agents.
Study findings suggest that men with end-stage kidney disease and localized or regional prostate cancer do not need to wait additional time for a kidney transplant because of the cancer.
Analysis of United Network for Organ Sharing data reveals a declining trend in patients receiving a kidney from a living donor from 2010 to 2019.
Kidney transplant recipients who are obese or are Black or Hispanic are at elevated risk of dying from COVID-19, a study found.
In a study, renal transplant recipients in the lowest quartile of skeletal muscle attenuation had 2-fold increased risk for new-onset diabetes after transplantation.
Compared with men of similar obesity class, the likelihood of women being waitlisted for kidney transplantation was significantly lower and this disparity increased as body mass index increased.
In a study, 71.8% of solid organ transplant recipients who tested positive for SARS-CoV-2 were kidney transplant recipients.
The highest risk for mortality was observed in the first year after kidney transplantation.
Study findings may help clinicians better understand immune response in kidney transplant recipients following COVID-19 vaccination.
Please login or register first to view this content.
